Our views on launch of Parliamentary Blood Cancer report
Read our response to The Hidden Cancer: The need to improve blood cancer care.
News
Read the latest news and views from Lymphoma Action.
Use the drop down filter to find the most relevant news for you.
Obinutuzumab not recommended for untreated follicular lymphoma in Scotland
Scottish Medicines Consortium chooses not to recommend obinutuzumab for treatment of follicular lymphoma.
NICE recommends ibrutinib for relapsed or refractory mantle cell lymphoma
NICE reverses its decision on ibrutinib for relapsed or refractory mantle cell lymphoma.
Young People's Live your Life workshop launched - Rachel explains
As someone who knows what it’s like to live with a lymphoma diagnosis, I am delighted that we have received funding from BUPA UK Foundation to run a programme of Live your Life workshops for young people aged 18-30.
£18,860 grant to benefit 18-30 year olds affected by lymphoma
We are delighted to be able to launch our Young People’s Live your Life programme, which will go live with our first workshop in Cambridge on 3 February.
Preliminary results: G100 in follicular lymphoma
Early results from the phase 1/2 trial of G100 are encouraging.
NICE recommends ibrutinib for relapsed or refractory mantle cell lymphoma
NICE reverses decision on Ibrutinib and recommends it for baseline commissioning in England.
£250,000 grant will help expand our work across the UK
'Exceptional' grant to help boost our regional networks and help us reach more people across the UK.
Kat shares her experience of attending a Lymphoma Masterclass
Kat, a Macmillan Haematology Nurse Specialist, shares how attending our Lymphoma Masterclass helped her focus for the year ahead.
Newer drug on NHS for systemic anaplastic large cell lymphoma
Brentuximab vedotin recommended as treatment option for systemic anaplastic large cell lymphoma.